PROTEOSOMES, EMULSOMES, AND CHOLERA-TOXIN-B IMPROVE NASAL IMMUNOGENICITY OF HUMAN-IMMUNODEFICIENCY-VIRUS GP160 IN MICE - INDUCTION OF SERUM, INTESTINAL, VAGINAL, AND LUNG IGA AND IGG
Gh. Lowell et al., PROTEOSOMES, EMULSOMES, AND CHOLERA-TOXIN-B IMPROVE NASAL IMMUNOGENICITY OF HUMAN-IMMUNODEFICIENCY-VIRUS GP160 IN MICE - INDUCTION OF SERUM, INTESTINAL, VAGINAL, AND LUNG IGA AND IGG, The Journal of infectious diseases, 175(2), 1997, pp. 292-301
Intranasal immunization of mice with human immunodeficiency virus (HIV
) rgp160 complexed to proteosomes improved anti-gp160 serum IgA and Ig
G titers, increased the number of gp160 peptides recognized, and stimu
lated anti-gp160 intestinal IgA compared with immunization with uncomp
lexed rgp160 in saline, These enhanced responses were especially evide
nt when either a bioadhesive nanoemulsion (emulsomes) or cholera toxin
B subunit (CTB) was added to the proteosome-rgp160 vaccine, Furthermo
re, anti-gp160 Ige and IgA in vaginal secretions and fecal extracts we
re induced after intranasal immunization with proteosome-rgp160 delive
red either in saline or with emulsomes, Formulation of uncomplexed rgp
160 with emulsomes or CTB also enhanced serum and selected mucosal IgA
responses, Induction of serum, vaginal, bronchial, intestinal, and fe
cal IgA and IgG by intranasal proteosome-rgp160 vaccines delivered in
saline or with emulsomes or CTB is encouraging for mucosal vaccine dev
elopment to help control the spread of HIV transmission and AIDS.